Insulet Gross Profit 2010-2025 | PODD

Insulet annual/quarterly gross profit history and growth rate from 2010 to 2025. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • Insulet gross profit for the quarter ending March 31, 2025 was $409M, a 33.31% increase year-over-year.
  • Insulet gross profit for the twelve months ending March 31, 2025 was $1.548B, a 26.24% increase year-over-year.
  • Insulet annual gross profit for 2024 was $1.446B, a 24.64% increase from 2023.
  • Insulet annual gross profit for 2023 was $1.16B, a 43.98% increase from 2022.
  • Insulet annual gross profit for 2022 was $0.806B, a 7.11% increase from 2021.
Insulet Annual Gross Profit
(Millions of US $)
2024 $1,446
2023 $1,160
2022 $806
2021 $752
2020 $582
2019 $480
2018 $370
2017 $277
2016 $211
2015 $133
2014 $127
2013 $112
2012 $92
2011 $67
2010 $44
2009 $18
Insulet Quarterly Gross Profit
(Millions of US $)
2025-03-31 $409
2024-12-31 $431
2024-09-30 $377
2024-06-30 $331
2024-03-31 $307
2023-12-31 $361
2023-09-30 $293
2023-06-30 $265
2023-03-31 $241
2022-12-31 $217
2022-09-30 $188
2022-06-30 $190
2022-03-31 $210
2021-12-31 $213
2021-09-30 $189
2021-06-30 $183
2021-03-31 $168
2020-12-31 $161
2020-09-30 $152
2020-06-30 $143
2020-03-31 $127
2019-12-31 $134
2019-09-30 $123
2019-06-30 $116
2019-03-31 $107
2018-12-31 $110
2018-09-30 $102
2018-06-30 $82
2018-03-31 $76
2017-12-31 $80
2017-09-30 $74
2017-06-30 $65
2017-03-31 $59
2016-12-31 $61
2016-09-30 $56
2016-06-30 $50
2016-03-31 $44
2015-12-31 $42
2015-09-30 $32
2015-06-30 $31
2015-03-31 $29
2014-12-31 $21
2014-09-30 $38
2014-06-30 $36
2014-03-31 $33
2013-12-31 $33
2013-09-30 $27
2013-06-30 $27
2013-03-31 $25
2012-12-31 $25
2012-09-30 $24
2012-06-30 $22
2012-03-31 $20
2011-12-31 $20
2011-09-30 $19
2011-06-30 $15
2011-03-31 $14
2010-12-31 $14
2010-09-30 $12
2010-06-30 $10
2010-03-31 $8
2009-12-31 $7
2009-09-30 $6
2009-06-30 $3
2009-03-31 $2
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $20.867B $2.072B
Insulet Corporation is a leading developer, manufacturer and marketer of the Omnipod Insulin Management System. The system is equipped with a self-adhesive, small and lightweight disposable tubeless Omnipod device along with the wireless and handheld Personal Diabetes Manager (PDM). The Omnipod System is an innovative, discreet and easy-to-use continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System consists of Omnipod Insulin Management System ('Omnipod') and the Omnipod DASH Insulin Management System - Insulet's next generation digital mobile Omnipod platform. Insulet has tied up with pharmaceutical and biotechnological companies using customized form of the Omnipod System to deliver a drug at a certain administered volume and over a specified period of time. Insulet has partnered with pharmaceutical and biotechnology companies to tailor the Omnipod System technology platform for the delivery of subcutaneous drugs across other therapeutic areas.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $232.025B 27.90
Boston Scientific (BSX) United States $151.510B 37.93
Stryker (SYK) United States $148.668B 31.08
EssilorLuxottica (ESLOY) France $135.285B 0.00
Medtronic (MDT) Ireland $113.608B 16.10
Lonza Group Ag (LZAGY) Switzerland $50.270B 0.00
Haleon (HLN) United Kingdom $45.147B 25.77
ResMed (RMD) United States $37.623B 28.26
GE HealthCare Technologies (GEHC) United States $34.433B 16.35
Agilent Technologies (A) United States $34.375B 22.41
Terumo (TRUMY) Japan $24.785B 32.19
Koninklijke Philips (PHG) Netherlands $23.187B 16.27
Zimmer Biomet Holdings (ZBH) United States $18.493B 11.88
Baxter (BAX) United States $15.734B 11.75
Smith & Nephew SNATS (SNN) United Kingdom $13.038B 0.00
Demant (WILYY) Denmark $8.971B 0.00
Sunny Optical Technology (SNPTF) China $8.561B 0.00
Bio-Rad Laboratories (BIO) United States $6.823B 23.74
Lantheus Holdings (LNTH) United States $5.702B 14.38
Prestige Consumer Healthcare (PBH) United States $3.885B 17.35
Perrigo (PRGO) Ireland $3.731B 9.46
Haemonetics (HAE) United States $3.650B 16.62
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.415B 28.38
ICU Medical (ICUI) United States $3.262B 24.05
QuidelOrtho (QDEL) United States $2.084B 14.34
LeMaitre Vascular (LMAT) United States $1.896B 42.38
AtriCure (ATRC) United States $1.566B 0.00
Acuren (TIC) United States $1.379B 0.00
AdaptHealth (AHCO) United States $1.286B 13.06
Phibro Animal Health (PAHC) United States $1.221B 15.61
Green Thumb Industries (GTBIF) United States $1.211B 27.24
Neogen (NEOG) United States $1.137B 14.56
BioLife Solutions (BLFS) United States $1.071B 0.00
InMode (INMD) Israel $0.971B 9.78
Kestra Medical Technologies (KMTS) United States $0.810B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.703B 0.00
Owens & Minor (OMI) United States $0.695B 5.76
Curaleaf Holdings (CURLF) Canada $0.643B 0.00
CeriBell (CBLL) United States $0.619B 0.00
Evolus (EOLS) United States $0.597B 0.00
Tilray Brands (TLRY) Canada $0.594B 0.00
Valneva SE (VALN) France $0.497B 0.00
Capricor Therapeutics (CAPR) United States $0.465B 0.00
Surmodics (SRDX) United States $0.429B 0.00
SNDL (SNDL) Canada $0.363B 0.00
VAREX IMAGING (VREX) United States $0.347B 12.77
Quanterix (QTRX) United States $0.327B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.322B 0.00
Sanuwave Health (SNWV) United States $0.299B 0.00
Cerus (CERS) United States $0.279B 0.00
Viemed Healthcare (VMD) United States $0.277B 23.40
Sanara MedTech (SMTI) United States $0.269B 0.00
ZimVie (ZIMV) United States $0.268B 12.19
Cresco Labs (CRLBF) United States $0.265B 0.00
Aurora Cannabis (ACB) Canada $0.256B 76.00
Brainsway (BWAY) Israel $0.243B 64.35
OraSure Technologies (OSUR) United States $0.227B 0.00
Canopy Growth (CGC) Canada $0.226B 0.00
Biote (BTMD) United States $0.222B 6.25
TriSalus Life Sciences (TLSI) United States $0.196B 0.00
Organigram Global (OGI) Canada $0.192B 0.00
High Tide (HITI) Canada $0.190B 0.00
Utah Medical Products (UTMD) United States $0.187B 15.23
Omeros (OMER) United States $0.183B 0.00
Verano Holdings (VRNOF) United States $0.181B 0.00
Vireo Growth (VREOF) United States $0.150B 0.00
Exagen (XGN) United States $0.148B 0.00
FitLife Brands (FTLF) United States $0.127B 15.61
TerrAscend (TSNDF) Canada $0.101B 0.00
Fonar (FONR) United States $0.097B 12.47
MacroGenics (MGNX) United States $0.093B 0.00
Jin Medical (ZJYL) China $0.091B 0.00
Apyx Medical (APYX) United States $0.090B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.085B 0.00
Veru (VERU) United States $0.085B 0.00
Quipt Home Medical (QIPT) United States $0.078B 0.00
Zynex (ZYXI) United States $0.073B 0.00
InterCure (INCR) Israel $0.072B 0.00
Agape ATP (ATPC) $0.069B 0.00
Jushi Holdings (JUSHF) United States $0.067B 0.00
Cytosorbents (CTSO) United States $0.066B 0.00
ImmuCell (ICCC) United States $0.060B 0.00
Nephros (NEPH) United States $0.041B 55.57
Modular Medical (MODD) United States $0.039B 0.00
United-Guardian (UG) United States $0.037B 12.84
Safety Shot (SHOT) United States $0.032B 0.00
Rockwell Medical (RMTI) United States $0.032B 0.00
Allurion Technologies (ALUR) United States $0.019B 0.00
INLIF (INLF) $0.016B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
IM Cannabis (IMCC) Canada $0.014B 0.00
Trinity Biotech (TRIB) Ireland $0.014B 0.00
Meihua Medical Technologies (MHUA) China $0.013B 0.00
Senestech (SNES) United States $0.011B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
Innovative Eyewear (LUCY) United States $0.007B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00